🇺🇸 FDA
Patent

US 8114406

Peptides and their utility in modulation of behavior of cells expressing α3β1 integrins

granted A61KA61K38/00A61P

Quick answer

US patent 8114406 (Peptides and their utility in modulation of behavior of cells expressing α3β1 integrins) held by The United States of America as Represented by the Secretary of the Department of Health and Human Services expires Mon Feb 09 2032 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The United States of America as Represented by the Secretary of the Department of Health and Human Services
Grant date
Tue Feb 14 2012 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Feb 09 2032 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
11
CPC classes
A61K, A61K38/00, A61P, A61P27/02, A61P29/00